Literature DB >> 8254069

An empirical typology of seriously and persistently mentally ill patients using symptom and social functioning factors.

M T Hannah.   

Abstract

This study generated an empirical, statistically based typology that used both symptom data and social functioning dimensions to define subtypes of seriously mentally ill patients. The intent of using social functioning information was to explore the degree to which it improves clinicians' understanding of and treatment planning for diverse subgroups of patients. Social functioning dimensions and symptom data collected on a group of SPMI (seriously and persistently mentally ill) patients were factor analyzed and then submitted to a cluster analysis that yielded five meaningful patient subtypes. Demonstrations of the usefulness of this classification included significant subgroup differences on clinically important external variables, including needs for specific types of treatment and service consumption. For comparison purposes, the failure of the DSM-III diagnostic classification to distinguish patients on the clinically relevant criteria also was demonstrated.

Entities:  

Mesh:

Year:  1993        PMID: 8254069     DOI: 10.1002/1097-4679(199309)49:5<622::aid-jclp2270490504>3.0.co;2-t

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  3 in total

1.  Correlates of functioning in a population with dual diagnoses: an examination of diagnosis and problem history.

Authors:  L C Jordan; D A Luke; C T Mowbray; S E Herman; W S Davidson; C Conklin
Journal:  J Ment Health Adm       Date:  1996

2.  Consensus judgments of discharge readiness based on paranoid behavior: to what are clinical staff responding?

Authors:  Julian A Salinas; Gordon L Paul; Justin R Springer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05       Impact factor: 4.328

3.  Typology of persons with severe mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jacques Tremblay
Journal:  BMC Psychiatry       Date:  2013-05-11       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.